China
Africa
Explore chapters and articles related to this topic
Sleep
Published in Carolyn Torkelson, Catherine Marienau, Beyond Menopause, 2023
Carolyn Torkelson, Catherine Marienau
Chronic insomnia affects 5% of the population. The person’s sleep system has gone awry—it’s in a state of disrepair and has stopped functioning properly. Chronic insomnia can have a major negative impact on your quality of life and health, and it needs to be treated.
Lifestyle and Diet
Published in Chuong Pham-Huy, Bruno Pham Huy, Food and Lifestyle in Health and Disease, 2022
Chuong Pham-Huy, Bruno Pham Huy
For hard insomnia, consulting a specialist is necessary. There are many drugs to fight insomnia such as barbiturates, benzodiazepines, antidepressants, melatonin, and so on (93). Their therapeutic effects are immediate, but their side effects are also important. Only the doctor can determine the necessary dosage and the duration of the treatment. Do not abuse these drugs. In terms of alternative medicine, acupuncture may be helpful to treat chronic insomnia, but this therapy is still not recognized by healthcare organizations (100). The results of this practice depend on the specialist. However, acupuncture does not give side effects. For hypersomnia and narcolepsy, no treatment can cure these two sleep disorders.
Behavioural Sleep Problems in Children and Adolescents
Published in Cathy Laver-Bradbury, Margaret J.J. Thompson, Christopher Gale, Christine M. Hooper, Child and Adolescent Mental Health, 2021
This chapter will focus on behavioural insomnia of childhood, the commonest cause of chronic insomnia in this age group. Chronic insomnia is defined by the International Classification of Sleep Disorders III as difficulties falling asleep or staying asleep for three or more nights a week over three or more months. While behavioural insomnias are common, practitioners need to be aware of the spectrum of sleep disorders that may present in childhood and, importantly, that behavioural insomnias may co-exist with other disorders, e.g. sleep apnoea or parasomnias.
Examining whether Changes in Sleep Habits Predict Long-Term Sustainment of Treatment Gains in Individual Remitted from Insomnia after CBT-I
Published in Behavioral Sleep Medicine, 2023
Parky H. Lau, Onkar S. Marway, Nicole E. Carmona, Colleen E. Carney
Future research would benefit from further study of individuals who relapsed after CBT-I. In this study, an overwhelming majority of participants retained good sleeper status at the 1-year mark, which speaks to the robust effects of CBT-I. However, there is clinical utility in understanding the trajectory for participants who experienced a relapse and evaluating important predictors of outcomes in this population. Additionally, we did not find any significant changes in bedtime or rise time variability over time. Given that reducing variability in sleep schedules is implicated as an important aspect of treatment for chronic insomnia in past studies (Cunningham & Shapiro, 2018), this is one important area to further explore. This may be particularly valuable in populations in which variable sleep schedules play a significant role in sleep problems, such as adolescents and young adults (e.g., Ghekiere et al., 2019).
A Scoping Study of Insomnia Symptoms in School Teachers
Published in Behavioral Sleep Medicine, 2023
Madelaine Gierc, Robyn A. Jackowich, Sandra Halliday, Judith R. Davidson
Symptoms of insomnia include difficulty falling asleep, staying asleep, and/or waking too early in the morning. Chronic insomnia disorder applies when these symptoms occur at least three times per week, are associated with impaired functioning, and persist for at least three months (American Academy of Sleep Medicine, 2014). People with chronic insomnia often experience irritability and depressive symptoms (Baglioni et al., 2011) and show impairments in cognitive functioning, especially attention, reaction time, problem solving, and working memory (Wardle-Pinkston et al., 2019). Over time, insomnia increases the likelihood of developing major depressive disorder, cardiovascular disease, and type 2 diabetes (Baglioni et al., 2011; LeBlanc et al., 2018; Sofi et al., 2014). These difficulties may have negative repercussions on teachers’ classroom performance given that teachers’ emotional wellbeing predicts effective classroom management, positive teacher-student interactions, and an enhanced learning environment (Jennings & Greenberg, 2009).
Brief Behavioral Treatment for Insomnia: A Meta-Analysis
Published in Behavioral Sleep Medicine, 2022
Misol Kwon, Jia Wang, Gregory Wilding, Suzanne S. Dickerson, Grace E. Dean
Although insomnia can occur on a short-term situational, recurrent, or persistent basis, those who are most negatively affected suffer prolonged insomnia (Morin & Benca, 2012). Two commonly recommended treatments for chronic insomnia are cognitive behavioral therapy (CBT) for insomnia and pharmacotherapy (Winkelman, 2015). While pharmacotherapy drugs such as benzodiazepine or Z-drugs (e.g., zopiclone, zolpidem, or zaleplon) are considered treatment options, limited evidence for long-term efficacy exists along with numerous side-effects and addiction risks (Atkin et al., 2018). Current evidence supports CBT for insomnia as a first-line treatment for insomnia due to its substantial clinical efficacy and good management stability (Edinger et al., 2021; Qaseem et al., 2016; Riemann et al., 2017).